{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:16:13Z","timestamp":1792631773280,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T00:00:00Z","timestamp":1285027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00592-010-0226-0","type":"journal-article","created":{"date-parts":[[2010,9,20]],"date-time":"2010-09-20T06:29:43Z","timestamp":1284964183000},"page":"61-69","source":"Crossref","is-referenced-by-count":459,"title":["Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study"],"prefix":"10.1007","volume":"48","author":[{"given":"Lei","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongzhu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengfen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,21]]},"reference":[{"key":"226_CR1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A et al (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047\u20131053","journal-title":"Diabetes Care"},{"key":"226_CR2","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI29103","volume":"116","author":"M Prentki","year":"2006","unstructured":"Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802\u20131812","journal-title":"J Clin Invest"},{"key":"226_CR3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11892-009-0027-4","volume":"9","author":"MI McCarthy","year":"2009","unstructured":"McCarthy MI, Zeggini E (2009) Genome-wide association studies in type 2 diabetes. Curr Diab Rep 9:164\u2013171","journal-title":"Curr Diab Rep"},{"key":"226_CR4","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/db09-1153","volume":"58","author":"CN Palmer","year":"2009","unstructured":"Palmer CN (2009) Novel insights into the etiology of diabetes from genome-wide association studies. Diabetes 58:2444\u20132447","journal-title":"Diabetes"},{"key":"226_CR5","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05616","volume":"445","author":"R Sladek","year":"2007","unstructured":"Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881\u2013885","journal-title":"Nature"},{"key":"226_CR6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrg2178","volume":"8","author":"TM Frayling","year":"2007","unstructured":"Frayling TM (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev 8:657\u2013662","journal-title":"Nat Rev"},{"key":"226_CR7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1464-5491.2007.02274.x","volume":"24","author":"E Zeggini","year":"2007","unstructured":"Zeggini E (2007) A new era for Type 2 diabetes genetics. Diabet Med 24:1181\u20131186","journal-title":"Diabet Med"},{"key":"226_CR8","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.2337\/db08-0504","volume":"57","author":"H Lango","year":"2008","unstructured":"Lango H, Palmer CN, Morris AD et al (2008) Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 57:3129\u20133135","journal-title":"Diabetes"},{"key":"226_CR9","first-page":"1686","volume":"8","author":"J Ji","year":"2009","unstructured":"Ji J, Wang XW (2009) New kids on the block: diagnostic and prognostic microRNAs in hepatocellular carcinoma. Cancer Biol Ther 8:1686\u20131693","journal-title":"Cancer Biol Ther"},{"key":"226_CR10","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen X, Ba Y, Ma L et al (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997\u20131006","journal-title":"Cell Res"},{"key":"226_CR11","doi-asserted-by":"crossref","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","volume":"3","author":"S Gilad","year":"2008","unstructured":"Gilad S, Meiri E, Yogev Y et al (2008) Serum microRNAs are promising novel biomarkers. PloS One 3:e3148","journal-title":"PloS One"},{"key":"226_CR12","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513\u201310518","journal-title":"Proc Natl Acad Sci USA"},{"key":"226_CR13","doi-asserted-by":"crossref","unstructured":"Huang Z, Huang D, Ni S et al (2009) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer","DOI":"10.1002\/ijc.25007"},{"key":"226_CR14","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1073\/pnas.0809999106","volume":"106","author":"DB Jackson","year":"2009","unstructured":"Jackson DB (2009) Serum-based microRNAs: are we blinded by potential? Proc Natl Acad Sci USA 106:E5","journal-title":"Proc Natl Acad Sci USA"},{"key":"226_CR15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbagrm.2008.06.010","volume":"1779","author":"X Tang","year":"2008","unstructured":"Tang X, Tang G, Ozcan S (2008) Role of microRNAs in diabetes. Biochim Biophys Acta 1779:697\u2013701","journal-title":"Biochim Biophys Acta"},{"key":"226_CR16","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1017\/S1462399408000781","volume":"10","author":"E Hennessy","year":"2008","unstructured":"Hennessy E, O\u2019Driscoll L (2008) Molecular medicine of microRNAs: structure, function and implications for diabetes. Exp Rev Mol Med 10:e24","journal-title":"Exp Rev Mol Med"},{"key":"226_CR17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000218169","volume":"23","author":"AK Pandey","year":"2009","unstructured":"Pandey AK, Agarwal P, Kaur K et al (2009) MicroRNAs in diabetes: tiny players in big disease. Cell Physiol Biochem 23:221\u2013232","journal-title":"Cell Physiol Biochem"},{"key":"226_CR18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1261\/rna.1211209","volume":"15","author":"X Tang","year":"2009","unstructured":"Tang X, Muniappan L, Tang G et al (2009) Identification of glucose-regulated miRNAs from pancreatic beta cells reveals a role for miR-30d in insulin transcription. RNA 15:287\u2013293","journal-title":"RNA"},{"key":"226_CR19","doi-asserted-by":"crossref","first-page":"19575","DOI":"10.1074\/jbc.M611841200","volume":"282","author":"N Baroukh","year":"2007","unstructured":"Baroukh N, Ravier MA, Loder MK et al (2007) MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem 282:19575\u201319588","journal-title":"J Biol Chem"},{"key":"226_CR20","doi-asserted-by":"crossref","first-page":"26932","DOI":"10.1074\/jbc.M601225200","volume":"281","author":"V Plaisance","year":"2006","unstructured":"Plaisance V, Abderrahmani A, Perret-Menoud V et al (2006) MicroRNA-9 controls the expression of Granuphilin\/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 281:26932\u201326942","journal-title":"J Biol Chem"},{"key":"226_CR21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature03076","volume":"432","author":"MN Poy","year":"2004","unstructured":"Poy MN, Eliasson L, Krutzfeldt J et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226\u2013230","journal-title":"Nature"},{"key":"226_CR22","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1210\/me.2007-0167","volume":"21","author":"A He","year":"2007","unstructured":"He A, Zhu L, Gupta N et al (2007) Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3\u2013L1 adipocytes. Mol Endocrinol 21:2785\u20132794","journal-title":"Mol Endocrinol"},{"key":"226_CR23","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/db07-1252","volume":"57","author":"P Lovis","year":"2008","unstructured":"Lovis P, Roggli E, Laybutt DR et al (2008) Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 57:2728\u20132736","journal-title":"Diabetes"},{"key":"226_CR24","doi-asserted-by":"crossref","unstructured":"(2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32(Suppl 1):S62\u2013S67","DOI":"10.2337\/dc09-S062"},{"key":"226_CR25","doi-asserted-by":"crossref","unstructured":"Ji J, Zhao L, Budhu A et al (2010) Let-7\u00a0g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 52:690\u2013697","DOI":"10.1016\/j.jhep.2009.12.025"},{"key":"226_CR26","unstructured":"Wong L, Lee K, Russell I et al (2007) Endogenous controls for real-time quantitation of miRNA using TaqMan MicroRNA assays. Macmillan Publishers Limited (all rights reserved), New York"},{"key":"226_CR27","doi-asserted-by":"crossref","unstructured":"Roggli E, Britan A, Gattesco S et al (2010) Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 59:978\u2013986","DOI":"10.2337\/db09-0881"},{"key":"226_CR28","doi-asserted-by":"crossref","unstructured":"Feng B, Chen S, George B et al (2010) miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev 26:40\u201349","DOI":"10.1002\/dmrr.1054"},{"key":"226_CR29","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1073\/pnas.0810550106","volume":"106","author":"MN Poy","year":"2009","unstructured":"Poy MN, Hausser J, Trajkovski M et al (2009) miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci USA 106:5813\u20135818","journal-title":"Proc Natl Acad Sci USA"},{"key":"226_CR30","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511806384","volume-title":"Experimental design and data analysis for biologists","author":"GP Quinn","year":"2002","unstructured":"Quinn GP, Keough MJ (2002) Experimental design and data analysis for biologists. Cambridge University Press, Cambridge"},{"key":"226_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2004.12.031","volume":"120","author":"E Berezikov","year":"2005","unstructured":"Berezikov E, Guryev V, van de Belt J et al (2005) Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120:21\u201324","journal-title":"Cell"},{"key":"226_CR32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/ng1590","volume":"37","author":"I Bentwich","year":"2005","unstructured":"Bentwich I, Avniel A, Karov Y et al (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37:766\u2013770","journal-title":"Nat Genet"},{"key":"226_CR33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15\u201320","journal-title":"Cell"},{"key":"226_CR34","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.2337\/db08-0047","volume":"57","author":"Y Wu","year":"2008","unstructured":"Wu Y, Li H, Loos RJ et al (2008) Common variants in CDKAL1, CDKN2A\/B, IGF2BP2, SLC30A8, and HHEX\/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes 57:2834\u20132842","journal-title":"Diabetes"},{"key":"226_CR35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00592-008-0080-5","volume":"46","author":"S-M Ruchat","year":"2009","unstructured":"Ruchat S-M, Elks C, Loos R et al (2009) Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol 46:217\u2013226","journal-title":"Acta Diabetol"},{"key":"226_CR36","doi-asserted-by":"crossref","unstructured":"Zhao J, Bradfield JP, Zhang H et al (2010) Examination of all type 2 diabetes GWAS loci reveals HHEX-IDE as a locus influencing pediatric BMI. Diabetes 59:751\u2013755","DOI":"10.2337\/db09-0972"},{"key":"226_CR37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1172\/JCI21149","volume":"114","author":"KA Lantz","year":"2004","unstructured":"Lantz KA, Vatamaniuk MZ, Brestelli JE et al (2004) Foxa2 regulates multiple pathways of insulin secretion. J Clin Invest 114:512\u2013520","journal-title":"J Clin Invest"},{"key":"226_CR38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/(SICI)1098-1004(1999)13:5<351::AID-HUMU3>3.0.CO;2-R","volume":"13","author":"T Meissner","year":"1999","unstructured":"Meissner T, Beinbrech B, Mayatepek E (1999) Congenital hyperinsulinism: molecular basis of a heterogeneous disease. Hum Mutat 13:351\u2013361","journal-title":"Hum Mutat"},{"key":"226_CR39","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/diacare.21.9.1408","volume":"21","author":"SF Dinneen","year":"1998","unstructured":"Dinneen SF, Maldonado D 3rd, Leibson CL et al (1998) Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care 21:1408\u20131413","journal-title":"Diabetes Care"},{"key":"226_CR40","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2337\/diabetes.52.6.1475","volume":"52","author":"JB Meigs","year":"2003","unstructured":"Meigs JB, Muller DC, Nathan DM et al (2003) The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore longitudinal study of aging. Diabetes 52:1475\u20131484","journal-title":"Diabetes"},{"key":"226_CR41","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJMoa050080","volume":"353","author":"A Tirosh","year":"2005","unstructured":"Tirosh A, Shai I, Tekes-Manova D et al (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353:1454\u20131462","journal-title":"N Engl J Med"},{"key":"226_CR42","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J Tuomilehto","year":"2001","unstructured":"Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343\u20131350","journal-title":"N Engl J Med"},{"key":"226_CR43","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.jada.2008.01.026","volume":"108","author":"LM Delahanty","year":"2008","unstructured":"Delahanty LM, Nathan DM (2008) Implications of the diabetes prevention programme and Look AHEAD clinical trials for lifestyle interventions. J Am Diet Assoc 108:S66\u2013S72","journal-title":"J Am Diet Assoc"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-010-0226-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-010-0226-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-010-0226-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T18:45:50Z","timestamp":1559673950000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-010-0226-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,21]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["226"],"URL":"https:\/\/doi.org\/10.1007\/s00592-010-0226-0","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,21]]}}}